Dear Valued Customer,
Fresenius Kabi Canada is pleased to announce the launch of Bivalirudin for Injection 250 mg/vial 10 mL.
The product is bar-coded, latex free and preservative free.
This product will be available Thursday, April 18, 2019 through all MDP and McKesson locations.
If you would like to obtain more information on this product, please contact your hospital representative or our Customer Service Department at (877) 821-7724.
Product Manager – IV Drugs